A detailed history of Temasek Holdings (Private) LTD transactions in Geron Corp stock. As of the latest transaction made, Temasek Holdings (Private) LTD holds 139,964 shares of GERN stock, worth $404,495. This represents 0.0% of its overall portfolio holdings.

Number of Shares
139,964
Holding current value
$404,495
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.17 - $4.99 $583,649 - $698,420
139,964 New
139,964 $635,000
Q1 2024

May 15, 2024

BUY
$1.75 - $3.44 $244,937 - $481,476
139,964 New
139,964 $461,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.09B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Temasek Holdings (Private) LTD Portfolio

Follow Temasek Holdings (Private) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Temasek Holdings (Private) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Temasek Holdings (Private) LTD with notifications on news.